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Cognitive deficits are a frequent symptom of Parkinson's disease (PD), particularly in the
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domain of spatial working memory (WM). Despite numerous demonstrations of aberrant
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WM in patients, there is a lack of understanding about how, if at all, their WM is funda-
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mentally altered. Most notably, it is unclear whether span e the yardstick upon which
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most WM models are built e is compromised by the disease. Moreover, it is also unknown
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whether WM deficits occur in all patients or only exist in a sub-group who are executively
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impaired. We assessed the factors that influenced spatial span in medicated patients by
varying the complexity of to-be-remembered items. Principally, we manipulated the ease

Keywords:

with which items could enter e or be blocked from e WM by varying the level of structure
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in memoranda. Despite having similar levels of executive performance to controls, PD
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patients were only impaired when remembering information that lacked spatial, easy-to-

Chunking

chunk, structure. Patients' executive function, however, did not influence this effect. The

Irrelevance

ease with which patients could control WM was further examined by presenting irrelevant

Attention

information during encoding, varying the level of structure in irrelevant information and
manipulating the amount of switching between relevant and irrelevant information. Disease did not significantly alter the effect of these manipulations. Rather, patients' executive
performance constrained the detrimental effect of irrelevant information on WM. Thus, PD
patients' spatial span is predominantly determined by level of structure in to-beremembered information, whereas their level of executive function may mitigate against
the detrimental effect of irrelevant information.
© 2017 Elsevier Ltd. All rights reserved.
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Introduction

Cognitive deficits, in addition to the characteristic motoric
problems, are a frequent symptom of Parkinson's disease (PD;
Brown & Marsden, 1988; Cools, 2006; Kehagia, Barker, &
Robbins, 2012; Monchi, Hanganu, & Bellec, 2016; Owen,
2004). Aberrant performance on working memory (WM)
tasks form a core component of these deficits (Bublak, Müller,
€ n, Reuter, & von Cramon, 2002; Cools, Miyakawa, Sheridan,
Gro
& D'Esposito, 2010; Lewis, Slabosz, Robbins, Barker, & Owen,
2005; Poewe, Berger, Benke, & Schelosky, 1991), with impairments most robustly seen in the spatial domain (Owen, Iddon,
Hodges, Summers, & Robbins, 1997; Postle, Jonides, Smith,
Corkin, & Growdon, 1997). Deficits on these tasks are largely
thought to occur due to the dopaminergic abnormalities that
characterise the disease (Sawamoto et al., 2008).
However, despite these demonstrations, we still lack an
understanding of whether the basic architecture of WM e how
information is encoded, stored and recalled e is altered in PD.
The amount of information that can be recalled e WM span e
is the basic currency in which different mnemonic models are
constructed, compared and evaluated (Fallon, Zokaei, &
Husain, 2016). Measures of WM span are also related to measures of real-world success (Gathercole, Brown, & Pickering,
2003). Thus, any exploration of the architecture of WM deficits in PD should seek to identify the factors that determine
WM span.
The Corsi block-tapping task is a common test of spatial
span (Milner, 1971). The basic structure of this task is to
require individuals to observe and encode a sequence of
spatial locations and then, after a short delay, reproduce this
sequence by touching the remembered locations. Although
there have been several studies of spatial span in PD patients
using Corsi-like tasks, the results have been mixed. Despite
numerous demonstrations of intact spatial spans in early
medicated PD, reduced spans have also been reported
(Fournet, Moreaud, Roulin, Naegele, & Pellat, 2000; Kemps,
Szmalec, Vandierendonck, & Crevits, 2005; Stoffers,
Berendse, Deijen, & Wolters, 2003). There are likely to be two
principal reasons for this: a failure to control for the
complexity of memoranda and cognitive heterogeneity (executive performance) in patients.
Here, we consider four factors that may influence the
complexity of memoranda: level of structure in the to-beremembered information, presence of irrelevant information, structure in the irrelevant information and degree of
switching that is required between relevant and irrelevant
information. Firstly, with regards to structure, most studies
that have examined spatial span in PD patients have failed to
control for the extent to which the to-be-remembered sequences can be re-organised into familiar or regular structures, i.e., the extent to which information can be chunked
(Miller, 1956). This factor has been found to be a key determinant of performance on span tasks, with higher spans and
concomitant increases in dorsolateral prefrontal cortex
(DLPFC) activity observed during the encoding of structured
verses unstructured material (Bor & Owen, 2007; Bor,
Cumming, Scott, & Owen, 2004; Bor, Duncan, Lee, Parr, &
Owen, 2006; Bor, Duncan, Wiseman, & Owen, 2003). The

failure to control for this factor may also lead to a misrepresentation of patients' mnemonic abilities, either because
encoding easily-chunked information ‘normalises’ their span
(due to it being easier), or, because they are unable to derive
the normative enhancement in spatial span when encoding
easily-chunked information. For example, patients with
moderate Alzheimer's disease fail to show improvements in
span when remembering structured material (Huntley, Bor,
Hampshire, Owen, & Howard, 2011).
Secondly, impaired span in PD patients may only appear
when irrelevant information has to be ignored. This line of
reasoning stems from observations that the basal ganglia e
particularly its modulation by dopamine e are thought to be
essential for filtering out irrelevant information (Baier et al.,
2010; Gruber, Dayan, Gutkin, & Solla, 2006; McNab &
Klingberg, 2008). In line with this, PD patients' WM deficits
have been found to be exacerbated by irrelevant information
(Lee et al., 2010).
Thirdly, however, there may be a modulatory role of
salience in influencing the detrimental effect of irrelevant
information. As the mirror-image of what occurs when relevant information is structured, were irrelevant information to
contain structure its salience may increase and thus be harder
to ignore. Such an effect could be anticipated on the basis that
PD patients have already been shown to have impaired capacity to ignore salient information in the attentional domain
(Cools, Rogers, Barker, & Robbins, 2010). Therefore, we sought
to determine whether a similar effect can be detected in the
mnemonic domain by varying the level of spatial structure in
the irrelevant as well as the relevant information.
Finally, the detrimental effect of irrelevant information on
patients' mnemonic performance may be contingent upon its
prior relevance, especially given the established literature
showing that this group has impairments in switching
attention and task sets (Cools, Barker, Sahakian, & Robbins,
2001; Fales, Vanek, & Knowlton, 2006; Hayes, Davidson,
Keele, & Rafal, 1998; Owen et al., 1993; Pollux, 2004). Indeed,
in support of this claim, Moustafa, Sherman, and Frank (2008)
found that mnemonic impairments in PD patients became
more pronounced when they had to remember previously
irrelevant information. Therefore, as a final manipulation of
the complexity of memoranda, this study varied the extent to
which participants had to update their demarcation between
relevant and irrelevant information by including a condition
in which they had to switch to attending to previously irrelevant information (where the relevant and irrelevant information were defined by colour; Fig. 1).
A perennial problem in characterising cognitive performance in PD is patient heterogeneity (Owen, 2004). For
example, only a subgroup of PD patients, in the absence of
dementia, exhibit deficits on so-called executive tasks such as
planning, WM and attention (Kehagia et al., 2012; Tremblay,
Achim, Macoir, & Monetta, 2013; Williams-Gray et al., 2013),
though estimates of prevalence vary (Aarsland et al., 2010).
Thus, the appearance of WM deficits in patients, and the
resulting conclusions, may greatly depend upon the baseline
executive performance level of that sample. One way to
circumvent this problem is to test a larger group of patients
with varying levels of executive performance. Performance on
the Tower of London (TOL) task has been used to stratify
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Fig. 1 e Illustration of the task and conditions. A) Schematic of the task protocol. Locations that had to be remembered were
indicated by the grey squares on a 4 £ 4 grid changing colour, sequentially. The number of locations was determined by the
current set size. Then, after the presentation of auditory tone, participants had to reproduce the sequence in the order in
which it appeared, by sequentially touching a square on the 4 £ 4 grid. Example trials from four blocks (Fig. 1BeE). In the
structured block (STR; Fig. 1C), the sequence of illuminated squares followed a predetermined rule which tended to produce
sequences which were easy to group into smaller chunks. Unstructured (UN) sequences (Fig. 1B), however, were prevented
from generating such patterns. In some blocks, participants were presented with two sequences: a relevant sequence that
had to be remembered and an irrelevant sequence that had to be ignored. In the structuredeunstructured (STReUN) block
(Fig. 1D), relevant information was structured and irrelevant information was unstructured. However, in the
unstructuredestructured (UNeSTR; Fig. 1E) block, the relevant information was unstructured and the irrelevant information
was structured. There was also an unstructuredeunstructured block where neither type of information was structured (not
shown).

patients into executively impaired and unimpaired groups
(Fallon, Hampshire, Barker, & Owen, 2016; Lewis, Cools et al.,
2003; Lewis, Dove, Robbins, Barker, & Owen, 2003). These
studies have revealed that executively impaired patients do
not have a generic deficit with WM but only perform poorly
when information in WM has to be manipulated and show a
preserved ability to effectively maintain information (Lewis,
Cools et al., 2003). However, whether this conclusion holds
true across the variations in the complexity of memoranda
mentioned above has yet to be investigated. It could be
hypothesised that patients' level of executive functioning is a
key moderating variable in influencing the effect that the
complexity of memoranda has on their spatial spans. This
factor may also have played a role in generating some findings
using WM span tasks in patients. Recently, in a relatively
small group of patients, varying the level of structure in the tobe-remembered information did not significantly affect WM
span (Gruszka, Bor, Barker, Necka, & Owen, 2016). One possibility is that e in addition to being potentially underpowered e
patient heterogeneity may have masked the appearance of
any selective deficit in remembering unstructured material.
Therefore, in this study we also sought to examine the extent
to which PD patients' spatial span performance is determined

by the level of structure in the to-be-remembered information, while also examining the modulatory role of executive
performance.

2.

Methods

2.1.

Participants

The study complied with the 1975 Helsinki declaration and
was approved by the local ethics committee (National
research ethics committee e Norfolk 08/H0306/26). All subjects gave informed consent prior to participating in the
study. PD patients and healthy older adults without a history
of previous neurological complaints (e.g., stroke or head jury)
or reported psychiatric illness were invited to take part in the
study. All patients had a Mini Mental Status Score (MMSE)
28. To ensure a degree of medication homogeneity, only
patients that were taking some form of dopaminergic medication were included in this study. Furthermore, given the
aim of this study was to examine the role of executive
functioning in influencing WM, included participants had to
have completed the TOL planning task from the Cambridge
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Neuropsychological Test Automated Battery (CANTAB). This
test assesses general executive functioning and performance
has been found to be provide a good index of cognition in PD
patients (Fallon, Hampshire et al., 2016; Lewis, Cools et al.,
2003).
Data from 35 healthy older adults and 38 patients were
included in this study. The mean age for controls was 63.49
(SD ¼ 5.7) and for patients was 66.34 (SD ¼ 7.2). These two
groups did not statistically differ in age [t(71) ¼ 1.86, p ¼ .066].
Patients were taking a variety of dopaminergic medications
(see Supplementary Table). Equivalent levodopa dose was
calculated using a standard algorithm [(Levodopa dose  1.2 if
COMT inhibitor) (1.2 if 10 mg of Selegiline or 1.1 if 5 mg of
Selegiline)] þ [Pramipexole  400] þ [ropinirole  40] þ
[Cabergoline  160].

2.2.

Design and procedure

Both groups performed other cognitive tasks prior to starting
the spatial span task; PD performed an attention set-shifting
task (data to be reported elsewhere), whereas controls performed the TOL test from the CANTAB test battery. PD patients did not need to complete this test battery on the testing
day as they had already completed this battery as part of a
prior clinical assessment.
Participants viewed the spatial span task on a 1500 CTX
touch-screen monitor (resolution: 1024  768). Participants
were inducted into the task using written instructions and
randomly assigned a colour and order assignment. After
this, participants completed two practice blocks, one run of
the unstructured block and one run of the structured block.
The order in which each block was performed was counterbalanced. The initial sequence length of these practice
blocks was 1 square and there were 7 trials in each block.
After the practice session, participants completed the three
phases of the experiment. The spatial span task required
participants to memorise, and reproduce, a sequence of
spatial locations that were illuminated on a 4  4 grid of grey
squares against a black background (see Fig. 1). A coloured
bar was present at the bottom of the screen to indicate the
target colour. For each trial, a sequence of squares flashed in
the relevant and irrelevant (where appropriate, see below)
colour. Each square remained illuminated for 1000 msec and
flashes were separated by a 500 msec interval. At the end of
the sequence a short tone prompted participants to make
their response (using their right index finger). Participants
were given a fixed time window within which to respond,
determined by the length of the sequence of squares participants were presented with (1000 msec þ 400 msec for
each square). At the end of each trial, participants were
informed (on the screen) whether they had got the answer
correct. This experiment used a ratchet design: correct trials
led to an increase in sequence length for the next trial by
one square and incorrect trials led to a decrease in sequence
length by one square. This was done so as to estimate participants' span e amount of information that could be
remembered e and because a previous study that did not
find differences between patients and controls in remembering structured information only used a fixed set size, i.e.,
four items (Gruszka et al., 2016).

In total, there were 7 blocks, with 10 trials per block. The
starting sequence length of each block was determined by the
average sequence length of the previous block (rounded
down). For the first block of the testing session, the starting
sequence length was set to three. In all the conditions, no
square (spatial location) could appear more than once within a
sequence. Spatial span was measured for each condition, by
taking the average length of the last five trials for each block.
Spatial span was assessed across three separate phases.
The order of these phases was not randomised to prevent
carry over effects which could be expected to be larger in patients given their reported deficits in cognitive switching. The
first phase examined spatial span during the encoding of
unstructured (UN block) and structured (STR block) material
without any irrelevant material. Different target colours were
used for each block, and the order in which participants
completed these two blocks was counter-balanced. As in Bor
et al. (2003), a structured sequence was generated by
ensuring that the next square in the sequence was always
from the same row, column or diagonal line as the previous
square in the sequence (i.e., it could move like the queen piece
in chess). However, unstructured sequences involved no such
moves (see Fig. 1).
In the second phase of the experiment, two sequences
appeared simultaneously on the screen: a target sequence and
non-target irrelevant sequence (presented in different colours). The same square could feature in both the target and
irrelevant sequence, but not simultaneously. The experimental manipulation in this phase consisted of varying the
level of structure in the relevant sequence or in the irrelevant
sequence. There were three blocks within this phase: a block
where neither the relevant sequence nor the irrelevant
sequence was structured (UNeUN block); a structured/unstructured block, where the relevant sequence was structured
but the irrelevant sequence was unstructured (STReUN
block); and finally an unstructured/structured block, where
the irrelevant sequence was structured but the relevant
sequence was unstructured (UNeSTR block). These are displayed in Fig. 1. A separate colour combination was used for
each block. The order in which each block was completed and
the colour assignment for each block was also counterbalanced across participants (12 different colours were used
across the experiment).
The third and final phase of the experiment introduced a
switching component into the task. Whereas in the previous
two phases of the task the target colour remained constant
through the duration of the block, in this phase of the experiment the target colour could change at several points during
the block. This phase consisted of two blocks, which varied
the level of structure in the irrelevant sequence. There was an
unstructured/unstructured block (SWeUNeUN) and an unstructured/structured block (SWeUNeSTR; similar to the
previous phase of the experiment, but with the addition of the
switching element). Again, the colour combinations of these
two blocks differed, as did the order in which participants
completed these two tasks. The colour assignments were also
counter-balanced across participants, with each block having
a different colour for any given subject.
The results were analysed (in SPSS 19.0) using two separate
mixed analysis of variances (ANOVAs). These analyses
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examined two separate questions: i) whether the effect of
introducing structure varied according to whether relevant or
irrelevant information was present (UN, STR, UNeUN and
STReUN blocks), ii) whether the effect of structured information in the irrelevant sequence on spatial span varied according
to the requirement to switch between relevant and irrelevant
sequences (UNeUN, UNeSTR, SWeUNeUN, SWeUNeSTR).

3.

Results

3.1.
PD patients and controls had equivalent levels of
overall executive functioning
There was no significant difference between patients and
controls in the total number of problems solved on the TOL
[t(71) ¼ .093, p ¼ .926]. Thus, patients and controls showed
equivalent levels of executive performance.

3.2.

Structure normalises PD patients' span

To examine the effect that irrelevant information and its
interaction with structure in the relevant sequence had on
spans, performance on the UN, STR, UNeUN and STReUN
blocks were analysed with a mixed ANOVA with repeated
measures on structure in the relevant sequence (structured,
unstructured), irrelevant information (present, absent) and
disease as a between-subject variable. Level of executive
function (performance on the TOL) was entered as a meancentred covariate.
Spans were higher when sequences were spatially structured [F(1, 68) ¼ 12.45, p ¼ .001] and patients had significantly
lower spatial spans than healthy controls [F(1,68) ¼ 6.56,
p ¼ .013]. However, there was a significant interaction between spatial structure and disease [F(1,68) ¼ 6.97, p ¼ .010].
Patients only had significantly lower spans when encoding
unstructured sequences [t(68) ¼ 3.69, p ¼ .0004], but were not
significantly impaired when recalling structured sequences
[t(68) ¼ 1.02, p ¼ .314]. Moreover, while patients had significantly higher spans when recalling structured compared to
unstructured sequences [t(37) ¼ 4.62, p ¼ .00004], this effect
was absent in the healthy older adults [t(34) ¼ .70, p ¼ .49].
Thus, encoding and maintaining structured information normalised patients' spans.
Across patients and controls, the presence of an irrelevant
sequence did not significantly affect spans [F(1,70) ¼ 3.60,
p ¼ .062]. There was no significant interaction with disease
[F(1,68) ¼ 1.40, p ¼ .24], level of executive performance (F < 1) or
spatial structure [F(1,68) ¼ 1.22, p ¼ .27]. There was no threeway interaction between disease, spatial structure and presence of irrelevant information [F(1,68) ¼ 2.36, p ¼ .129].
With regards to the other factors, executive functioning
significantly affected overall spatial spans [F(1,68) ¼ 11.04,
p ¼ .001], with higher executive performance being associated
with higher spans. However, despite this tight coupling between executive performance and overall span performance,
this covariate did not interact with the effect of spatial
structure (F < 1). Thus, executive performance did not
modulate the beneficial effects of structure or modulate patients' performance on this task.
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3.3.
The beneficial effects of structure on span is
modulated by the level of dopaminergic medication
Supplementary analyses examined the effect of Unified Parkinson's Disease Rating Scale (UPDRS) motor score and level
of dopaminergic medication in modulating the relationship
between the above experimental factors in influencing
span in PD patients. There was no significant effect of UPDRS
score on span and neither did it significantly interact with
any experimental factor (Fs < 1). Equivalent L-dopa dose was
found to have a significant effect on patients' spatial span
[F(1,36) ¼ 4.78, p ¼ .035], with higher doses being associated
with lower spans. Notably, equivalent L-dopa dose was found
to significantly interact with structure and the presence of
irrelevant information [F(1,36) ¼ 5.04, p ¼ .031]. This three-way
interaction was due to levodopa dose having a significant
positive correlation with the mnemonic gain for remembering
structured versus unstructured material in the presence of
irrelevant information correlation (DSTRUN, UNUN) with
levodopa dose [r(38) ¼ .360, p ¼ .026; Fig. 2B], but there was no
correlation between the difference in the spans for the single
sequence structured and unstructured blocks (DSTR,UN) with
levodopa dose [r(38) ¼ 150, p ¼ .343]. Thus, medication seems
to exert its effects through bolstering the performance gain
induced by the existence of structure in to-be-remembered
information, specifically when irrelevant information is
present.
In summary, whereas patients and controls did not react
differently to the introduction of irrelevant information, they
did react differently to the introduction of spatial structure in
to-be-remembered spatial sequences. Patients appeared to
extract a mnemonic benefit from the introduction of spatial
structure and were able to attain normal levels of performance. Also, although level of executive performance was
associated with differences in spatial span, performance on
the TOL did not modulate the effect of the other experimental
variations.

3.4.
PD patients' span is not modulated by switching
and the presence of irrelevant information
The effect of introducing a switching component into the task
in the presence of structured irrelevant information was
assessed by comparing performance on the UNeUN, UNeSTR,
SWeUNeUN and SWeUNeSTR blocks with a mixed ANOVA
with repeated measures on structure in the irrelevant
sequence (unstructured, structured) and switching (nonswitching, switching) with disease as a between-subject variable and executive performance as a covariate (meancentred). One healthy control subject and one PD patient had
missing data for one or more of the cells involved in this
analysis and were therefore excluded from the analysis.
Across these four conditions, patients had significantly
lower spans than healthy older adults [F(1,68) ¼ 13.79,
p ¼ .0004]. However, patients' impairment varied significantly
across the experimental factors; there was a three-way
interaction between disease, switching and the presence/
absence of structure in the irrelevant sequence [F(1,68) ¼ 5.91,
p ¼ .018]. Breaking this interaction down, there was no significant interaction between switching and level of structure
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Fig. 2 e PD patients and controls spatial span. A) Span performance for PD patients and controls, split according to whether
an irrelevant sequence was simultaneously presented and whether the relevant memoranda was structured or
unstructured. PD patients were significantly impaired when remembering unstructured sequences but not structured
sequences. Error bars reflect the standard error of the mean. B) The relationship between patients' equivalent levodopa
medication dose (see method) and mnemonic gain from encoding structured sequences. The latter was calculated by
subtracting spatial spans on unstructured blocks (UN and UNeUN) from structured blocks (STR and STReUN). A higher score
on this measure indicates patients' span improved when encoding structured compared to unstructured sequences.

in the irrelevant sequence for PD patients (F < 1). In contrast,
in controls, these two factors significantly interacted
[F(1,33) ¼ 7.08, p ¼ .012]. This two-way interaction in controls
was itself due to structure in the irrelevant sequence having
opposite effects in switching and non-switching contexts. In
non-switching contexts, irrelevant structure impaired spatial
spans [t(33) ¼ 2.17, p ¼ .037], whereas there was a trend towards controls having higher spans when irrelevant structure
was present in switching contexts [t(33) ¼ 1.88, p ¼ .069]. With
regards to the main analysis, all other interactions with disease were not significant (Fs < 1).
Similar to the previous section above, there was a significant effect of the level of executive functioning on spatial span
scores [F(1,68) ¼ 13.21, p ¼ .001], with higher scores on the TOL
being associated with higher spatial spans. In addition, there
was a significant interaction between the level of executive
performance and the effect of irrelevant information in
influencing spatial spans [F(1,68) ¼ 6.54, p ¼ .013]. This interaction was due to there being a significant positive correlation
between executive performance and the mnemonic cost of
structure in the irrelevant sequence [r(71) ¼ .296, p ¼ .012], i.e.,
participants with higher levels of executive performance
experienced a greater decrease in their spans by having to deal
with structure in the irrelevant dimension. This pattern was
only found to be significant in patients [r(37) ¼ .392, p ¼ .016;
Fig. 3B], but not controls [r(34) ¼ .078, p ¼ .66]. Level of executive performance did not significantly correlate with any
other variable (Fs < 1).
Thus, in summary, the above analysis yielded two main
findings. Firstly, in controls but not patients, it appeared that
the level of attention that was given to the relevant and
irrelevant sequences (induced by switching) determined the
beneficial or detrimental effect of irrelevant structure. When
no switching occurred, irrelevant structure impaired spans,
but when switching occurred, irrelevant structure improved
spans. This effect was entirely absent in PD patients.

Secondly, in patients but not controls, the level of executive
functioning appeared to influence the mnemonic cost of
introducing structure into the irrelevant sequence; costs were
most prominent in those patients with the higher level of
executive functioning.

3.5.
Medication dose did not alter the effect of irrelevant
information
Supplementary analyses examined, separately, the effect of
entering UPDRS motor score and equivalent L-dopa dose as
covariates in the above analysis (for patients only). UPDRS did
not have a significant main effect on span [F(1,40) ¼ 1.44,
p ¼ .23] and there was a trend towards UPDRS modulating the
effect of switching on spatial span [F(1,40) ¼ 3.67, p ¼ .06] and
no significant three-way interaction between UPDRS, switching and the structure in the irrelevant sequence [F(1,40) ¼ 1.19,
p ¼ .28]. For equivalent L-dopa dose, there was a trend towards
a main effect on span [F(1,41) ¼ 2.86, p ¼ .098], but none of the
other effects were significant (Fs < 1).

3.6.
No evidence for differential fatigue in patients and
controls
One potential confound in our design is whether patients and
controls experienced differential fatigue across the three
phases study or merely responded different to the increasing
difficult of the phases (addition of irrelevant information and
switching).
To this end, we examined performance across the three
phases of the experiment; phase 1 (single unstructured and
structured sequences), phase 2 (unstructured with irrelevant
unstructured sequences, structured relevant and unstructured irrelevant sequences, and unstructured relevant and
structured relevant sequences), phase 3 (switching with unstructured relevant sequences and irrelevant unstructured
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Fig. 3 e Span and switching. A) Spatial span for PD patients and controls in switching and non-switching contexts, split
according to whether the irrelevant information was structured or unstructured. PD patients were unaffected by the
experimental manipulation of structure in the irrelevant sequence or the need to switch. In contrast, controls were either
aided (switching) or impaired (non-switching) by the presence of structured irrelevant information. Error bars reflect the
standard error of the mean. B) Significant positive relationship between executive functioning (performance on the Tower of
London; TOL) and the cost to span spatial incurred by irrelevant structure for PD patients only. The cost from irrelevant
structure was calculated by subtracting spatial spans for the structured conditions (UNeSTR and SWeUNSTR) from the
unstructured irrelevant information conditions (UNeUN and SWeUNUN). A higher score on this metric indicates that spans
decreased when ignoring structured irrelevant information.

sequences, and switching with unstructured relevant sequences and structured irrelevant sequences). There was a
main effect of phase [F(2,140) ¼ 14.91, p < .001], with patients
and controls having progressively lower spans across the
three phases, but, crucially, there was no significant interaction between time and disease (F < 1). Thus, there is no evidence that patients were declining (or fatiguing) more rapidly
compared to controls.

4.

Discussion

This study has revealed a new pattern of when, and under
what conditions, PD patients show a reduction in their spatial
span e the amount of information that can be held for a short
period of time. A fundamental asymmetry in the way that PD
patients deal with structure in relevant and irrelevant information was discovered. Structure in the relevant information
normalises PD patients' spatial span, irrespective of executive
performance level. The specific, dopamine-related, nature of
this effect was underlined by the finding that the extent to
which patients' performance improved with structured presentations was related to their level of medication. In contrast,
these effects were not recapitulated in the case of dealing with
structured irrelevant information e it was the patients' level of
executive functioning that predicted whether they would
show impaired or enhanced spatial spans.

4.1.
Chunking relevant information normalises WM in
PD patients
In the absence of encoding structured information, patients
were generally found to show impaired spans compared to
controls (Figs. 2A and 3A). Chunking is thought to be both an
automatic and conscious process (Rossi-Arnaud, Pieroni, &

Baddeley, 2006). That is, while chunking can occur automatically, information from long-term memory can also be
recruited to impose structure on processed stimuli. Psychologically, the ability to chunk is thought to be facilitated by
the episodic buffer, which together with the central executive, phonological loop and visuo-spatial sketch pad are
thought to constitute the main components of WM
(Baddeley, 2000). The episodic buffer is thought to facilitate
the binding of information into chunks, and is itself
controlled by executive processes, thus providing a conduit
between working and long-term memory. This suggests that,
in certain conditions, the psychological mechanisms that
enable WM to take place retain their functionality in PD patients. Specifically, the fact that easy-to-chunk information
normalised WM in patients implies that when the need to
endogenously structure mental representations is bypassed,
patients can store equivalent amounts of information as
controls. However, deficits in the amount of information
patients can store become readily apparent in the absence
of that structure, suggesting that it is the inability to
self-organise mnemonic material that lies at the core of
patients' poor short-term recall.
The ability of structure in memoranda to act as a cognitive
prosthesis in patients could stem from two, possibly related
factors; a deficit in endogenously organising memoranda
[applying top-down control (Cools, Miyakawa, et al., 2010)]; or
that there may be increased neuronal noise in the parkinsonian brain that makes such control harder to execute (Bays,
2014; Manohar et al., 2015). Previous work has pointed to a
dissociation in the neurocognitive origins of patients'
impairment on maintaining versus manipulating items in
WM. Withdrawing patients from their dopaminergic state has
no effect on the ease with which items can be maintained, but
it does affect the manipulation of items in WM (Lewis et al.,
2005). Within the present data there are also suggestions
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that the enhanced performance on conditions that contain
structured information is present is related to patients'
dopaminergic state. Patients who were taking the highest
level of dopaminergic medication received the most benefit to
their spans when recalling structured information. Although,
equivalent levodopa dose is a poor measure of dopaminergic
state e given that it is usually correlated with disease progression e there was no relationship between the UPDRS
score (a marker of disease severity) and the performance gains
from structure. Therefore, higher levels of dopamine appear
to support a greater normalisation of spatial span by
structure.
The results of this experiment differ slightly from a previous, similar study that used a smaller patient cohort (Gruszka
et al., 2016). In addition to the possible differences in patient
sample, there are also methodological differences between
the two studies. In the previous study, participants were only
tested on a fixed set size (four spatial locations). In the present
study, however, participants were tested using a staircase (or
ratchet) design, whereby the length of each spatial sequence
would progressively increase. Thus, it is possible that the
ratchet method is more sensitive at revealing differences between patients and controls. Indeed, larger differences between patients and controls have been found using this
method (Fournet et al., 2000).

4.2.
Disease removes the sensitivity to switching and
structured irrelevant information
Contrary to previous studies that have found patients' impairments to be exacerbated in switching contexts (Cools
et al., 2001; Fales et al., 2006; Hayes et al., 1998; Pollux, 2004;
Ravizza & Ciranni, 2002), their spatial spans were not modulated by the need to rapidly update their demarcation between
relevant and irrelevant information (switching) or the introduction of salient, structured irrelevant information (Fig. 3B).
Thus, this suggests that there may be limited impact of previously relevant e but now irrelevant e information on patients' short-term recall, and that previous studies that have
shown patients to be disproportionately affected by these
manipulations (Fallon, Hampshire, et al., 2016; Owen et al.,
1993; Slabosz et al., 2006) may only have applicability in
attentional set-shifting contexts.
Unlike patients, healthy controls' spans were significantly
affected by the need to switch attention and whether structured irrelevant information was present. For controls, it
appeared that the effect of structured irrelevant information
on spans had opposite effects in switching and non-switching
contexts. In a non-switching context, and thus when attention was singularly focused on one feature dimension, structured irrelevant information impaired spans. Yet, there was a
trend for the reverse situation in switching contexts. Thus, the
extent to which attention has to be switched, or updated,
appears to modulate the effect that structured, potentially
more salient, irrelevant information has on recall; in low
updating context, salient irrelevant information is detrimental to performance, but in high updating contexts, salient
irrelevant information can be beneficial, presumably because
it becomes easier to ignore. Therefore, this finding demonstrates the heterogeneous nature of the effects irrelevant

information can have on WM and that the level of updating, or
switching, that occurs determines how structured (potentially
salient) information is dealt with.

4.3.
Executive performance modulates the effect of
irrelevant information in patients
Although disease modulated the beneficial effect of structure
on span, the same could not be said for structure in the
irrelevant sequence. Rather, it was the level of executive
performance, specifically in patients, that determined
whether spans were improved or impaired by irrelevant
structure. Patients with high executive functioning were
impaired by irrelevant structure, whereas those with low executive performance were enhanced by irrelevant structure
(Fig. 3B). Thus, patients with different levels of executive
functioning seem to have opposite responses to structured
irrelevant information. For high functioning patients, structured irrelevant information seems to attract attention in a
way that is relatively detrimental to eventual recall. However,
in low functioning patients, structured irrelevant information
enhanced performance of patients, presumably by making
irrelevant information easier to ignore.
In patients with high levels of executive performance, poor
filtering of irrelevant information may have led to that information being cached in episodic buffer-like operations, ultimately producing a maladaptive form of chunking. That is,
the failure to effectively filter irrelevant information may have
led to the build-up of highly salient (distracting) information.
Given that PD patients have been found to be impaired in
ignoring salient information (Cools, Rogers, Barker, & Robbins,
2010), this irrelevant information could have a greater capacity to interfere with mnemonic representations in PD patients,
but seemingly only in those with high levels of executive
performance.
Based upon the effects observed in the controls, we can
make several hypotheses about the cognitive mechanisms
underlying this process. For the controls, it was found that in
switching contexts, irrelevant structure improved WM,
whereas in non-switching contexts, irrelevant structure
increased spans. Thus, the difference in performance according to executive functioning may have arisen due to a difference in the extent to which they mentally switch between the
relevant and irrelevant sequences, i.e., high executive functioning patients are impaired by structure because they do not
switch, whereas low executive functioning patients are
improved because they do switch. Although plausible, further
research, possibly with eye tracking or neural markers of
attention, will be necessary to establish whether patients
switch between the relevant and irrelevant sequences.
Despite this study's success in characterising which
experimental manipulations influence spatial span performance in PD patients, this study has several limitations that
constrain and qualify the inferences that can be made. Firstly,
a key omission in this study is the lack of a condition where
both the relevant and irrelevant sequences were spatially
structured. As such, it remains to be determined whether, if
both the relevant and irrelevant sequences were spatially
structured, there would be a protective influence of spatial
structure in the relevant information.
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Another limitation of this study is the extent to which it
can comment upon how other forms of cognitive heterogeneity in patients modulate WM. Cognitive heterogeneity in PD
is a multifaceted problem which has several dimensions
(Kehagia et al., 2012). This study only assessed the role of one
component of cognitive heterogeneity in patients e executive
functioning as assessed by the TOL. As mentioned earlier,
performance on this task is thought to be an indicator of
fronto-striatal integrity (Lewis, Dove, et al., 2003; Nombela
et al., 2014). It is likely that other indices of differential
cognitive performance in patients e such as those that are
dependent upon medial temporal lobe (MTL) or posterior
cortical regions e could be seen to influence WM performance
in patients. Indeed, patients with moderate Alzheimer's disease, a disorder associated with disruption to MTL regions,
have been found to have a reduced ability to derive the
mnemonic benefit from encoding structured sequences
(Huntley et al., 2011). Future studies should evaluate whether
other metrics of cognitive heterogeneity in PD patients affect
patients' performance.
In summary, this study has, in a novel paradigm,
confirmed previous suggestions that the capacity of medicated PD patients to encode new items into WM is limited, but
crucially that this impairment can be normalised by having
patients encoding structured memoranda. In contrast, the
beneficial or detrimental effect of irrelevant information is
highly dependent upon patients' level of executive functioning. By identifying the exact circumstances in which PD
patients show impaired WM this study has further specified
the precise cognitive substrates that require therapeutic
intervention in PD patients.

Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.cortex.2017.08.023.
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